Inhibition of vascular permeability by cycloheximide in granulomatous inflammation

Gene testing and prognosis in post-operative recurrent non-small-cell lung cancer: subgroup analyses of WJOG15421L.

ESMO open·2026

Caste development and sex ratio of the Ryukyu drywood termite Neotermes sugioi and its potential mechanisms.

Scientific reports·2021

Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study.

ESMO open·2021

Sodium-glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low-carbohydrate diet.

Diabetes, obesity & metabolism·2015

Effects of luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, on 24-h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, crossover study.

Diabetes, obesity & metabolism·2015

The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Macrophage-intrinsic STAT3 drives LPS-induced acute lung injury: allosteric blockade by K116 and genetic validation via conditional knockout.

Biochemical pharmacology·2026

PARP1-targeting PROTAC attenuates alcohol-associated liver injury and ileal epithelial damage.

Biochemical pharmacology·2026

Celastrol induces mitochondrial apoptosis in hepatocellular carcinoma by suppressing LRP6-associated Wnt/β-catenin signaling.

Biochemical pharmacology·2026

Zinc gluconate attenuates oxaliplatin-induced pulmonary injury via suppressing the TLR4/NF-κB signaling.

Biochemical pharmacology·2026

Colchicine reduces aortic dissection and aneurysm formation in mice by inhibiting the IL-17A/RA-MAPK pathway.

Biochemical pharmacology·2026

RNF5: an emerging therapeutic target for modulating immunity and metabolism.

Biochemical pharmacology·2026

The association between cardiac arrhythmia and autoantibodies in systemic sclerosis.

Modern rheumatology·2026

Statin-induced myopathy is rare.

Danish medical journal·2026

Related Experiment Videos

Inhibition of vascular permeability by cycloheximide in granulomatous inflammation

Related Concept Videos

Gene testing and prognosis in post-operative recurrent non-small-cell lung cancer: subgroup analyses of WJOG15421L.

Caste development and sex ratio of the Ryukyu drywood termite Neotermes sugioi and its potential mechanisms.

Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study.

Sodium-glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low-carbohydrate diet.

Effects of luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, on 24-h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, crossover study.

The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors.

Macrophage-intrinsic STAT3 drives LPS-induced acute lung injury: allosteric blockade by K116 and genetic validation via conditional knockout.

PARP1-targeting PROTAC attenuates alcohol-associated liver injury and ileal epithelial damage.

Celastrol induces mitochondrial apoptosis in hepatocellular carcinoma by suppressing LRP6-associated Wnt/β-catenin signaling.

Zinc gluconate attenuates oxaliplatin-induced pulmonary injury via suppressing the TLR4/NF-κB signaling.

Colchicine reduces aortic dissection and aneurysm formation in mice by inhibiting the IL-17A/RA-MAPK pathway.

RNF5: an emerging therapeutic target for modulating immunity and metabolism.

The association between cardiac arrhythmia and autoantibodies in systemic sclerosis.

Statin-induced myopathy is rare.

Related Experiment Videos

Inhibition of vascular permeability by cycloheximide in granulomatous inflammation

Related Concept Videos

Related Articles